Results 161 to 170 of about 50,545 (304)

Cannabinoid CB ₁ Receptor Antagonist AM251 Inhibits Cocaine-Primed Relapse in Rats: Role of Glutamate in the Nucleus Accumbens [PDF]

, 2006
Zheng‐Xiong Xi, Jeremy G. Gilbert, Xiao‐Qing Peng, Arlene C. Pak, Xia Li, Eliot L. Gardner   +5 more
openalex   +1 more source

The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases

, 2021
Aleksandra Kicman, Anna Pędzińska‐Betiuk, Hanna Kozłowska   +2 more
openalex   +1 more source

Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well‐documented intoxication cases and basic pharmacological data

Addiction, Volume 121, Issue 4, Page 870-882, April 2026.
Abstract Background and aims While the health hazards of synthetic cannabinoid receptor agonists (SCRAs) are often approximated using in vitro pharmacological parameters as surrogate, this approach fails to consider pharmacokinetic and pharmacodynamic complexity.
Michaela J. Sommer, Katharina Elisabeth Grafinger, Maren Hermanns‐Clausen, Volker Auwärter   +3 more
wiley   +1 more source

Sex‐specific impact of repeated adolescent vapour exposure to JWH‐018 on dopamine response, behaviour and pharmacokinetics across adolescence and adulthood

British Journal of Pharmacology, Volume 183, Issue 7, Page 1517-1538, April 2026.
Abstract Background and Purpose Alarming trends show that vaping e‐cigarettes containing synthetic cannabinoid receptor agonists, such as JWH‐018, is increasing among youth. However, the effects of these trends are unclear in both sexes. We therefore characterized the neuropharmacological effects of adolescent JWH‐018 inhalation in male and female rats.
Nicholas Pintori, Cristina Manis, Enrica Spano, Nicola Simola, Alessandro Ieraci, Pierluigi Caboni, Gaetano Di Chiara, Maria Antonietta De Luca   +7 more
wiley   +1 more source

Cannabinoid modulation of behavioral processes : from adolescence to adulthood

, 2021
Christina Ioannidou
openalex   +1 more source

Use of 13C-qNMR Spectroscopy for the Analysis of Non-Psychoactive Cannabinoids in Fibre-Type Cannabis sativa L. (Hemp) [PDF]

, 2019
Lucia Marchetti, Virginia Brighenti, Maria Cecilia Rossi, Johanna Sperlea, Federica Pellati, Davide Bertelli   +5 more
openalex   +1 more source

Combined extraction and spray-freeze-drying of Cannabis sativa Flos provides stable lyophilizate particles of cannabinoids. [PDF]

J Cannabis Res
Kožák J, Vázquez-Olvera JI, Berkenfeld K, Rautenberg A, Lamprecht A.   +4 more
europepmc   +1 more source

Context-Dependent Risks of THC: Why Indication-Aware Framing Is Essential in Cannabinoid Medicine

Anwar Mohamed
openalex   +1 more source

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

British Journal of Pharmacology, Volume 183, Issue 7, Page 1364-1389, April 2026.
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen, Declan P. McKernan, John P. Kelly   +2 more
wiley   +1 more source

Phytocannabinoids and Male Fertility: Implications of <i>Cannabis sativa</i> and the Endocannabinoid System in Reproductive Regulation. [PDF]

Plants (Basel)
Erukainure OL, Nambooze J, Chukwuma CI.
europepmc   +1 more source